In Vitro Toxicology Market - Trends Forecast Till 2028

In Vitro Toxicology Market, By Product (Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion), Industry (Pharmaceutical, Cosmetics) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: April, 2021

Base Year Estimate: 2020

Report ID: D-PH-IVTM-140

Format:  

Number of Pages: 419

Domain: Pharmaceutical

In Vitro Toxicology Market – Trends Forecast Till 2028

Global in Vitro Toxicology market is anticipated to reach USD 10.8 billion in 2021 growing at a CAGR of 11.5% during the forecasting period, 2021-2028.

In vitro toxicology is a set of technique used to study and identify the effect of various toxins on bacteria and other organisms. As a result of these testing only a drug or chemical is verified for human use. There are various methods like cytotoxicity, toxicokinetics etc. It also leads to develop a dose response relationship.

With an increased research in the sector along with the recent opposition to animal testing are some of the factors that have supported long-term expansion for In Vitro Toxicology industry.

In Vitro Toxicology Market Report

Global In Vitro Toxicology market is segmented into Product, Toxicity Endpoints, Industry and geography.

Product segment is segmented into Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, and Software

Toxicity Endpoints segment is segmented into ADME, Skin Irritation, Corrosion

Industry segment is segmented into Pharmaceutical, Cosmetics

Geographically, global In Vitro Toxicology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Key players in global In Vitro Toxicology market are Thermo Fisher Scientific Inc. (US), Eurofins Scientific SE (Luxembourg), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), BioRad Laboratories, QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US), Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and  Insphero (Switzerland) among others.

Available Customizations

In addition to the market data for In Vitro Toxicology market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conference like Jefferies conference)—to identify and collect information useful for this study of the In Vitro Toxicology market. The purpose of secondary research was to identify and collection of extensive, technical, market-oriented, and commercial study the global In Vitro Toxicology market. Through secondary the market is classified and segmented as per of industry trend, development, regional market. Product and technology development.

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the In Vitro Toxicology market.

Primary Respondent breakdown is given below:

In Vitro Toxicology Market Primary Respondents

 

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validating the total revenue of the In Vitro Toxicology market. This approach has also been used to derive the market for segmentation and sub-segmentation.

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact primary respondent in order to gain 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for In Vitro Toxicology market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 10.8 billion

Growth Rate

CAGR of 11.5% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product , Toxicity Endpoints ,Industry and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Thermo Fisher Scientific Inc. (US), Eurofins Scientific SE (Luxembourg), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), BioRad Laboratories, QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US), Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and  Insphero (Switzerland)

Available Customization

In addition to the market data for In Vitro Toxicology market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.